{"id":"https://openalex.org/A5012279869","orcid":"https://orcid.org/0000-0002-3091-8168","observed_orcids":["https://orcid.org/0000-0002-3091-8168"],"display_name":"Tetsuhiko Taira","raw_author_names":["Tetsuhiko Taira"],"full_name":"Tetsuhiko Taira","works_count":4,"cited_by_count":281,"summary_stats":{"2yr_mean_citedness":90.66666666666667,"h_index":3,"i10_index":2},"ids":{"openalex":"https://openalex.org/A5012279869","orcid":"https://orcid.org/0000-0002-3091-8168","observed_orcids":["https://orcid.org/0000-0002-3091-8168"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4405282981","ror":"https://ror.org/00sg0ab04","display_name":"Sagara Hospital","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282981"]},"years":[2026,2024,2022]}],"last_known_institutions":[{"id":"https://openalex.org/I4405282981","ror":"https://ror.org/00sg0ab04","display_name":"Sagara Hospital","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282981"]}],"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","count":3,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","count":2,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10444","display_name":"Context-Aware Activity Recognition Systems","count":1,"subfield":{"id":"https://openalex.org/subfields/1707","display_name":"Computer Vision and Pattern Recognition"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","value":6.4e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","value":1.68e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","value":8e-06,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","value":7.7e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","value":6e-06,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9286588430404663},{"id":"530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","score":0.7097846865653992},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6835832595825195},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.6307215690612793},{"id":"121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","score":0.48394373059272766}],"counts_by_year":[{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":1},{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":3},{"year":2024,"works_count":2,"oa_works_count":2,"cited_by_count":4},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":102},{"year":2026,"works_count":1,"oa_works_count":0,"cited_by_count":171}],"display_name_alternatives":["Tetsuhiko Taira"],"block_key":"t taira","works_api_url":"https://api.openalex.org/works?filter=author.id:A5012279869","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5012279869","updated_date":"2026-11-12T13:17:38","created_date":"2022-07-31T00:00:00"}